Clay Siegall, president and CEO of Immunome, discusses what he saw investors getting excited for at the annual healthcare conference.Pharmaceutical Executive: What trends did you see at this year’s JP Morgan Healthcare Conference?Clay Siegall: I’ve been going to this conference for 25 years. In some years, it’s very exciting. In other years, it’s down. I’ve […]
